LASABSELasa Supergenerics LtdMinimalNeutral
Announced Fri, 29 May · 21:09 IST

Related party transaction as on 31 st march 2026

LASA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-9.3%1-day move
₹8.45
prior close
₹8.35
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.9-1.9-1.9-2.2-9.3-9.3-9.1-5.9-9.5-9.1-11.1-10.1
Up moveDown movePending
AI summary

Lasa Supergenerics Ltd has filed its half-yearly and annual related party transaction disclosure for the period ending March 31, 2026. The filing covers transactions with key management personnel including the CMD, Whole Time Directors, CFO, and Company Secretary, where the total approved value across all related parties was ₹618. The total value of transactions executed during the reporting period was ₹35.36. Notable transactions include Director Remuneration to CMD Omkar Herlekar (₹3.00), Whole Time Directors (totaling ₹6.42), sitting fees to multiple Independent Directors, and a donation of ₹15.50 to Dr Omkar Herlekar Foundation — a related entity sharing a common director with the company.

Likely market impact

The related party transactions appear routine, covering primarily remuneration and sitting fees for directors and key management. However, the donation to a foundation controlled by a common director warrants monitoring for any conflict of interest. No material impact on stock price is expected from this routine regulatory filing.